Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
37
BV Quote, Financials, Valuation and Earnings
Last price:
$13.88
Seasonality move
:
-3.91%
Day range:
$13.45 - $13.96
52-week range:
$11.06 - $17.11
Dividend yield:
0%
P/E ratio:
313.79x
P/S ratio:
0.50x
P/B ratio:
1.04x
Volume:
633K
Avg. volume:
583.4K
1-year change:
-4.79%
Market cap:
$1.3B
Revenue:
$2.7B
EPS (TTM):
-$0.01
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $2.8B | $2.8B | $2.8B | $2.7B | |
| Revenue Growth (YoY) | 8.85% | 8.65% | 1.49% | -1.74% | -3.41% | |
| Cost of Revenues | $2B | $2.2B | $2.2B | $2.2B | $2.1B | |
| Gross Profit | $596.2M | $621.8M | $634.4M | $609.8M | $592.7M | |
| Gross Profit Margin | 23.35% | 22.41% | 22.53% | 22.04% | 22.18% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $508M | $534.9M | $533.4M | $496.5M | $457.8M | |
| Other Inc / (Exp) | $2.7M | -$15.5M | -$6.7M | $45.6M | -- | |
| Operating Expenses | $456.5M | $502M | $509.3M | $452.4M | $431.7M | |
| Operating Income | $139.7M | $119.8M | $125.1M | $157.4M | $161M | |
| Net Interest Expenses | $35.5M | $52.8M | $112.6M | $73.5M | $59.4M | |
| EBT. Incl. Unusual Items | $50.9M | $19.6M | -$3.1M | $96.5M | $81.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.6M | $5.6M | $4.6M | $30.1M | $25.3M | |
| Net Income to Company | $46.3M | $14M | -$7.7M | $66.4M | $56M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $46.3M | $14M | -$7.7M | $66.4M | $56M | |
| Basic EPS (Cont. Ops) | $0.44 | $0.14 | -$0.12 | $0.21 | $0.13 | |
| Diluted EPS (Cont. Ops) | $0.44 | $0.14 | -$0.12 | $0.20 | $0.13 | |
| Weighted Average Basic Share | $105.2M | $97.9M | $93.4M | $94.7M | $95.2M | |
| Weighted Average Diluted Share | $105.7M | $98.2M | $93.4M | $96.1M | $96.5M | |
| EBITDA | $276.7M | $270.2M | $274.8M | $301.6M | $332.5M | |
| EBIT | $139.7M | $119.8M | $125.1M | $157.4M | $161M | |
| Revenue (Reported) | $2.6B | $2.8B | $2.8B | $2.8B | $2.7B | |
| Operating Income (Reported) | $139.7M | $119.8M | $125.1M | $157.4M | $161M | |
| Operating Income (Adjusted) | $139.7M | $119.8M | $125.1M | $157.4M | $161M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $591.8M | $655.9M | $626.7M | $599.2M | $614.7M | |
| Revenue Growth (YoY) | 6.75% | 10.83% | -4.45% | -4.39% | 2.59% | |
| Cost of Revenues | $466.8M | $520.2M | $503M | $480.1M | $506.5M | |
| Gross Profit | $125M | $135.7M | $123.7M | $119.1M | $108.2M | |
| Gross Profit Margin | 21.12% | 20.69% | 19.74% | 19.88% | 17.6% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $134.9M | $137.6M | $129.9M | $119.3M | $115.2M | |
| Other Inc / (Exp) | $700K | $700K | $1.2M | $200K | -- | |
| Operating Expenses | $125.8M | $132.5M | $119.2M | $110.1M | $108.2M | |
| Operating Income | -$800K | $3.2M | $4.5M | $9M | -- | |
| Net Interest Expenses | $8.9M | $26.2M | $2.6M | $16.2M | $14.3M | |
| EBT. Incl. Unusual Items | -$17.4M | -$24.4M | -$22.1M | -$14.6M | -$20.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$4.6M | -$5.5M | -$5.7M | -$4.2M | -$5.2M | |
| Net Income to Company | -$12.8M | -$18.9M | -$16.4M | -$10.4M | -$15.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$12.8M | -$18.9M | -$16.4M | -$10.4M | -$15.2M | |
| Basic EPS (Cont. Ops) | -$0.12 | -$0.20 | -$0.27 | -$0.20 | -$0.26 | |
| Diluted EPS (Cont. Ops) | -$0.12 | -$0.20 | -$0.27 | -$0.20 | -$0.26 | |
| Weighted Average Basic Share | $105.3M | $93.3M | $94M | $95.2M | $94.7M | |
| Weighted Average Diluted Share | $105.3M | $93.3M | $94M | $95.2M | $94.7M | |
| EBITDA | $34M | $42.2M | $40.2M | $47.5M | $49.1M | |
| EBIT | -$800K | $3.2M | $4.5M | $9M | -- | |
| Revenue (Reported) | $591.8M | $655.9M | $626.7M | $599.2M | $614.7M | |
| Operating Income (Reported) | -$800K | $3.2M | $4.5M | $9M | -- | |
| Operating Income (Adjusted) | -$800K | $3.2M | $4.5M | $9M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $2.8B | $2.8B | $2.7B | $2.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2B | $2.2B | $2.2B | $2.1B | $2.1B | |
| Gross Profit | $600.7M | $632.6M | $622.4M | $605.2M | $581.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $519.5M | $537.7M | $525.6M | $485.9M | $453.8M | |
| Other Inc / (Exp) | $1.9M | -$15.3M | -$6.4M | $44.6M | -- | |
| Operating Expenses | $470.2M | $508.8M | $495.7M | $443.3M | $429.9M | |
| Operating Income | $130.5M | $123.8M | $126.7M | $161.9M | $152M | |
| Net Interest Expenses | $35.5M | $70.3M | $91.8M | $69.8M | $57.6M | |
| EBT. Incl. Unusual Items | $49.2M | $12.7M | -$900K | $104M | $75.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.7M | $4.8M | $4.3M | $31.6M | $24.3M | |
| Net Income to Company | $45.5M | $7.9M | -$5.2M | $72.4M | $51.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $45.5M | $7.9M | -$5.2M | $72.4M | $51.2M | |
| Basic EPS (Cont. Ops) | $0.43 | $0.08 | -$0.18 | $0.17 | $0.00 | |
| Diluted EPS (Cont. Ops) | $0.43 | $0.08 | -$0.18 | $0.17 | -$0.01 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $266.8M | $278.3M | $273.1M | $308.9M | $334M | |
| EBIT | $130.5M | $123.8M | $126.7M | $161.9M | $152M | |
| Revenue (Reported) | $2.6B | $2.8B | $2.8B | $2.7B | $2.7B | |
| Operating Income (Reported) | $130.5M | $123.8M | $126.7M | $161.9M | $152M | |
| Operating Income (Adjusted) | $130.5M | $123.8M | $126.7M | $161.9M | $152M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $591.8M | $655.9M | $626.7M | $599.2M | $614.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $466.8M | $520.2M | $503M | $480.1M | $506.5M | |
| Gross Profit | $125M | $135.7M | $123.7M | $119.1M | $108.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $134.9M | $137.6M | $129.9M | $119.3M | $115.2M | |
| Other Inc / (Exp) | $700K | $700K | $1.2M | $200K | -- | |
| Operating Expenses | $125.8M | $132.5M | $119.2M | $110.1M | $108.2M | |
| Operating Income | -$800K | $3.2M | $4.5M | $9M | -- | |
| Net Interest Expenses | $8.9M | $26.2M | $2.6M | $16.2M | $14.3M | |
| EBT. Incl. Unusual Items | -$17.4M | -$24.4M | -$22.1M | -$14.6M | -$20.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$4.6M | -$5.5M | -$5.7M | -$4.2M | -$5.2M | |
| Net Income to Company | -$12.8M | -$18.9M | -$16.4M | -$10.4M | -$15.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$12.8M | -$18.9M | -$16.4M | -$10.4M | -$15.2M | |
| Basic EPS (Cont. Ops) | -$0.12 | -$0.20 | -$0.27 | -$0.20 | -$0.26 | |
| Diluted EPS (Cont. Ops) | -$0.12 | -$0.20 | -$0.27 | -$0.20 | -$0.26 | |
| Weighted Average Basic Share | $105.3M | $93.3M | $94M | $95.2M | $94.7M | |
| Weighted Average Diluted Share | $105.3M | $93.3M | $94M | $95.2M | $94.7M | |
| EBITDA | $34M | $42.2M | $40.2M | $47.5M | $49.1M | |
| EBIT | -$800K | $3.2M | $4.5M | $9M | -- | |
| Revenue (Reported) | $591.8M | $655.9M | $626.7M | $599.2M | $614.7M | |
| Operating Income (Reported) | -$800K | $3.2M | $4.5M | $9M | -- | |
| Operating Income (Adjusted) | -$800K | $3.2M | $4.5M | $9M | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $123.7M | $20.1M | $67M | $140.4M | $74.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $490.1M | $527.8M | $585.8M | $553M | $506.2M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $97M | $129.2M | $89.3M | $86.7M | -- | |
| Total Current Assets | $710.8M | $677.1M | $742.1M | $780.1M | $666.3M | |
| Property Plant And Equipment | $333.9M | $409.9M | $401.3M | $473.2M | $613.7M | |
| Long-Term Investments | $31.7M | $17.9M | $39.4M | $13.4M | $25.1M | |
| Goodwill | $2B | $2B | $2B | $2B | -- | |
| Other Intangibles | $197.6M | $174.3M | $132.3M | $95.8M | -- | |
| Other Long-Term Assets | $44.5M | $35.4M | $55.1M | $27M | -- | |
| Total Assets | $3.3B | $3.4B | $3.4B | $3.5B | $3.5B | |
| Accounts Payable | $144.4M | $151.2M | $136.2M | $144.1M | $137.7M | |
| Accrued Expenses | $220.9M | $193.5M | $158.7M | $200.7M | -- | |
| Current Portion Of Long-Term Debt | $10.4M | $12M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $22M | $26.8M | $48.8M | $61.9M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $496.1M | $488.4M | $466.7M | $543.3M | $514.5M | |
| Long-Term Debt | $1.2B | $1.4B | $974.5M | $896.3M | $880.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2B | $2.2B | $1.7B | $1.7B | $1.7B | |
| Common Stock | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | |
| Other Common Equity Adj | -- | $2M | $17.1M | -$1.5M | -- | |
| Common Equity | $1.3B | $1.2B | $1.2B | $1.3B | $1.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.3B | $1.2B | $1.7B | $1.8B | $1.8B | |
| Total Liabilities and Equity | $3.3B | $3.4B | $3.4B | $3.5B | $3.5B | |
| Cash and Short Terms | $123.7M | $20.1M | $67M | $140.4M | $74.5M | |
| Total Debt | $1.2B | $1.4B | $974.5M | $933.3M | $925.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $132.8M | $22.4M | $64.5M | $98.3M | $37M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $467.4M | $533.8M | $526.7M | $487M | $466.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $111.5M | $139M | $99.7M | $100.7M | -- | |
| Total Current Assets | $711.7M | $695.2M | $690.9M | $686M | $598.8M | |
| Property Plant And Equipment | $345.4M | $418.9M | $388.8M | $478.4M | $609.2M | |
| Long-Term Investments | $37M | $10.4M | $18.1M | $35.8M | $29.9M | |
| Goodwill | $2B | $2B | $2B | $2B | -- | |
| Other Intangibles | $189M | $163.4M | $122.1M | $87.7M | -- | |
| Other Long-Term Assets | $48.5M | $34.6M | $40.2M | $39.9M | -- | |
| Total Assets | $3.2B | $3.3B | $3.3B | $3.3B | $3.3B | |
| Accounts Payable | $144.1M | $132.8M | $120.2M | $122.5M | $114M | |
| Accrued Expenses | $165.9M | -- | $129.5M | $168.5M | -- | |
| Current Portion Of Long-Term Debt | $10.4M | $12M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $23.2M | $27.1M | $27.2M | $24.6M | -- | |
| Other Current Liabilities | -- | $168.2M | -- | -- | -- | |
| Total Current Liabilities | $456.4M | $461.1M | $421.2M | $479.3M | $475.5M | |
| Long-Term Debt | $1.3B | $1.5B | $945M | $856.1M | $856.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.9B | $2.1B | $1.5B | $1.5B | $1.6B | |
| Common Stock | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | |
| Other Common Equity Adj | -- | -- | $4.2M | $6.7M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.3B | $1.2B | $1.7B | $1.8B | $1.8B | |
| Total Liabilities and Equity | $3.2B | $3.3B | $3.3B | $3.3B | $3.3B | |
| Cash and Short Terms | $132.8M | $22.4M | $64.5M | $98.3M | $37M | |
| Total Debt | $1.3B | $1.5B | $945M | $856.1M | $856.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $46.3M | $14M | -$7.7M | $66.4M | $56M | |
| Depreciation & Amoritzation | $137M | $150.4M | $149.7M | $144.2M | $171.5M | |
| Stock-Based Compensation | $19.7M | $18.9M | $22.1M | $20.2M | $18.2M | |
| Change in Accounts Receivable | -$41.9M | -$6.3M | -$52.6M | $19.9M | $12.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $148.4M | $106.9M | $129.9M | $203.1M | $291.8M | |
| Capital Expenditures | $61.2M | $107.3M | $71.3M | $78.4M | $254.2M | |
| Cash Acquisitions | $110.4M | $93.1M | $13.8M | -- | -- | |
| Cash From Investing | -$158.7M | -$193.7M | -$61.4M | -$5.6M | -$223.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $17.8M | $35.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $34.5M | $1.7B | $583M | $500K | -- | |
| Long-Term Debt Repaid | -$55.5M | -$1.6B | -$1.1B | -$123.6M | -- | |
| Repurchase of Common Stock | $1.9M | $163.8M | $2.2M | $3.1M | $24.2M | |
| Other Financing Activities | -$2M | -$18.7M | -$24M | $14.4M | -- | |
| Cash From Financing | -$23.1M | -$16.8M | -$21.6M | -$124.1M | -$133.8M | |
| Beginning Cash (CF) | $123.7M | $20.1M | $67M | $140.4M | $74.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$33.4M | -$103.6M | $46.9M | $73.4M | -$65.9M | |
| Ending Cash (CF) | $90.3M | -$83.5M | $113.9M | $213.8M | $8.6M | |
| Levered Free Cash Flow | $87.2M | -$400K | $58.6M | $124.7M | $37.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$12.8M | -$18.9M | -$16.4M | -$10.4M | -$15.2M | |
| Depreciation & Amoritzation | $34.8M | $39M | $35.7M | $38.5M | $49.1M | |
| Stock-Based Compensation | $4.7M | $5.6M | $5.1M | $4.5M | $3.9M | |
| Change in Accounts Receivable | -$4.3M | -$15.6M | $21M | $20.7M | $24.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$22.4M | -$29.6M | $26.2M | $60.5M | $36.1M | |
| Capital Expenditures | $28.6M | $27.2M | $10.1M | $58.7M | $54.7M | |
| Cash Acquisitions | $6M | $10M | -- | -- | -- | |
| Cash From Investing | -$33.7M | -$35M | -$8.6M | -$55.3M | -$51.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $9M | $9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $75M | $195M | $500K | $1.6M | -- | |
| Long-Term Debt Repaid | -$8.2M | -$125.7M | -$17M | -$36.1M | -- | |
| Repurchase of Common Stock | $2.1M | $1.2M | $2.5M | $5.1M | $18.8M | |
| Other Financing Activities | -- | -$1.5M | -$1.3M | -$200K | -- | |
| Cash From Financing | $65.2M | $66.9M | -$20.1M | -$47.3M | -$21.8M | |
| Beginning Cash (CF) | $132.8M | $22.4M | $64.5M | $98.3M | $37M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.1M | $2.3M | -$2.5M | -$42.1M | -$37.5M | |
| Ending Cash (CF) | $141.9M | $24.7M | $62M | $56.2M | -$500K | |
| Levered Free Cash Flow | -$51M | -$56.8M | $16.1M | $1.8M | -$18.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $45.5M | $7.9M | -$5.2M | $72.4M | $51.2M | |
| Depreciation & Amoritzation | $136.3M | $154.6M | $146.4M | $147M | $182.1M | |
| Stock-Based Compensation | $19.5M | $19.8M | $21.6M | $19.6M | $17.6M | |
| Change in Accounts Receivable | -$23.2M | -$17.6M | -$16M | $19.6M | $15.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $120.9M | $99.7M | $185.7M | $237.4M | $267.4M | |
| Capital Expenditures | $80.1M | $105.9M | $54.2M | $127M | $250.2M | |
| Cash Acquisitions | $54.2M | $97.1M | $3.8M | -- | -- | |
| Cash From Investing | -$121M | -$195M | -$35M | -$52.3M | -$220.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $26.8M | $35.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $109.5M | $1.9B | $388.5M | $1.6M | -- | |
| Long-Term Debt Repaid | -$57.1M | -$1.7B | -$965.9M | -$142.7M | -- | |
| Repurchase of Common Stock | $2.9M | $162.9M | $3.5M | $5.7M | $37.9M | |
| Other Financing Activities | -- | -- | -$23.8M | $15.5M | -- | |
| Cash From Financing | $51.3M | -$15.1M | -$108.6M | -$151.3M | -$108.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $51.2M | -$110.4M | $42.1M | $33.8M | -$61.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $40.8M | -$6.2M | $131.5M | $110.4M | $17.2M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$12.8M | -$18.9M | -$16.4M | -$10.4M | -$15.2M | |
| Depreciation & Amoritzation | $34.8M | $39M | $35.7M | $38.5M | $49.1M | |
| Stock-Based Compensation | $4.7M | $5.6M | $5.1M | $4.5M | $3.9M | |
| Change in Accounts Receivable | -$4.3M | -$15.6M | $21M | $20.7M | $24.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$22.4M | -$29.6M | $26.2M | $60.5M | $36.1M | |
| Capital Expenditures | $28.6M | $27.2M | $10.1M | $58.7M | $54.7M | |
| Cash Acquisitions | $6M | $10M | -- | -- | -- | |
| Cash From Investing | -$33.7M | -$35M | -$8.6M | -$55.3M | -$51.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $9M | $9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $75M | $195M | $500K | $1.6M | -- | |
| Long-Term Debt Repaid | -$8.2M | -$125.7M | -$17M | -$36.1M | -- | |
| Repurchase of Common Stock | $2.1M | $1.2M | $2.5M | $5.1M | $18.8M | |
| Other Financing Activities | -- | -$1.5M | -$1.3M | -$200K | -- | |
| Cash From Financing | $65.2M | $66.9M | -$20.1M | -$47.3M | -$21.8M | |
| Beginning Cash (CF) | $132.8M | $22.4M | $64.5M | $98.3M | $37M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.1M | $2.3M | -$2.5M | -$42.1M | -$37.5M | |
| Ending Cash (CF) | $141.9M | $24.7M | $62M | $56.2M | -$500K | |
| Levered Free Cash Flow | -$51M | -$56.8M | $16.1M | $1.8M | -$18.6M | |
Get BV Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BV
Sector
P/E ratio
313.79x
20.33x
PEG ratio
--
0.18x
P/B ratio
1.04x
1.80x
Price / LTM sales
0.50x
0.89x
Growth Metrics
BV
Sector
Revenue growth
2.59%
4.57%
Earnings growth
-25.42%
3.54%
Revenue (5-year growth)
2.64%
4.49%
Earnings forecast
$0.01
$0.33
Profitability
BV
Sector
Profitability FY 2025
$592.7M
$238.5M
Return on invested capital
1.92%
4.52%
Return on assets
1.52%
3.09%
Return on equity
2.88%
7.99%
Earnings Date
Last Earnings Date
Feb
3
Next Earnings Date
May
6
Estimated Next Earnings Date
May
5
Balance Sheet
BV
Sector
Total cash
$37M
$138.4M
Short term investments
--
$31.1M
Total assets
$3.5B
$1.4B
Long term debt
$856.7M
$44.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
48
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 29x
Alerts
Buy
73
NKTR alert for Feb 11
Nektar Therapeutics [NKTR] is up 19.45% over the past day.
Buy
53
ICHR alert for Feb 11
Ichor Holdings Ltd. [ICHR] is up 5.66% over the past day.
Sell
26
MEDP alert for Feb 11
Medpace Holdings, Inc. [MEDP] is down 5% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
